737 North Fifth Street
Suite 200
Richmond, VA 23219
United States
650 870 1200
https://www.aditxt.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 47
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Amro A. Albanna | Co-Founder, Chairman & CEO | 472,12k | N/A | 1970 |
Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D. | Co-Founder, Chief Innovation Officer, Secretary & Director | 323,5k | N/A | 1963 |
Mr. Thomas J. Farley CPA | Chief Financial Officer | 357,89k | N/A | 1973 |
Ms. Corinne D. Pankovcin CPA, M.B.A. | Chief Commercialization Officer | 366,77k | N/A | 1966 |
Ms. Rowena Albanna | Chief Operating Officer | N/A | N/A | 1966 |
Ms. Jennifer Lee | Director of Human Resources | N/A | N/A | N/A |
Dr. Dolly B. Tyan Ph.D. | Senior Vice President of Clinical Development Transplantation | N/A | N/A | N/A |
Mr. Ge Chen M.D., M.S. | Senior Vice President of Preclinical Research & Discovery | N/A | N/A | N/A |
Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Aditxt, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.